Literature DB >> 23433333

Adductor tenotomy and selective obturator neurectomy for the treatment of spasticity in a man with paraplegia.

Ahmad Zaheer Qureshi1, Subramanya Adiga.   

Abstract

CONTEXT: Excessive hip adductor spasticity in patients with spinal cord injury (SCI) can produce scissoring effect of the thighs which can interfere with various activities of daily living. If noninvasive measures do not produce desired results, surgical treatment may be considered. One surgical option for the management of adductor spasticity includes adductor tenotomy and selective obturator neurectomy. This procedure was performed in an individual with T11 paraplegia having severe adductor spasticity in both thighs.
METHOD: Case report.
FINDINGS: Adductor spasticity at hips was identified as the main barrier in functional activities and rehabilitation of our patient. After a trial of noninvasive treatment, a selective obturator neurectomy and adductor tenotomy were carried out, which completely relieved his adductor spasticity at both thighs without any complications. With comprehensive rehabilitation, the patient showed enhanced functional independence in various activities of daily living. This helped the patient to achieve functional indoor ambulation using orthosis in spite of complete paraplegia. Conclusion/clinical reference: Severe adductor spasticity can have debilitating effects and could be a major barrier in rehabilitation of patients with SCI. Surgical treatment for adductor spasticity can be considered when patients are unresponsive to noninvasive treatment. Relief from adductor spasticity can improve functional outcomes and decrease dependency. Although this procedure is commonly performed in patients with cerebral palsy, it remains a viable surgical alternative in carefully selected patients with SCI when other modes of treatment are contraindicated, failed, or not available.

Entities:  

Mesh:

Year:  2013        PMID: 23433333      PMCID: PMC3555104          DOI: 10.1179/2045772312Y.0000000022

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  19 in total

1.  Treatment of intractable spasticity in spinal cord injured patients.

Authors:  S S Sangwan; S Chand; R C Siwach; I S Gupta
Journal:  Indian J Med Sci       Date:  1992-06

Review 2.  Pain and spasticity after spinal cord injury: mechanisms and treatment.

Authors:  K J Burchiel; F P Hsu
Journal:  Spine (Phila Pa 1976)       Date:  2001-12-15       Impact factor: 3.468

3.  Muscle release in the management of spasticity in spinal cord injury.

Authors:  I Eltorai; R Montroy
Journal:  Paraplegia       Date:  1990-09

4.  Spastic equinus foot: multicenter study of the long-term results of tibial neurotomy.

Authors:  Kevin Buffenoir; Thomas Roujeau; Françoise Lapierre; Philippe Menei; Dominique Menegalli-Boggelli; Patrick Mertens; Philippe Decq
Journal:  Neurosurgery       Date:  2004-11       Impact factor: 4.654

5.  Clinical and electromyographic evaluation of obturator neurectomy in severe spasticity.

Authors:  I Haftek
Journal:  Paraplegia       Date:  1987-10

6.  Current concepts of surgical management of deformities of the lower extremities in cerebral palsy.

Authors:  R L Samilson
Journal:  Clin Orthop Relat Res       Date:  1981 Jul-Aug       Impact factor: 4.176

Review 7.  Cerebral palsy.

Authors:  L Andrew Koman; Beth Paterson Smith; Jeffrey S Shilt
Journal:  Lancet       Date:  2004-05-15       Impact factor: 79.321

8.  Interrater reliability of a modified Ashworth scale of muscle spasticity.

Authors:  R W Bohannon; M B Smith
Journal:  Phys Ther       Date:  1987-02

Review 9.  Neurosurgical management of abnormal muscle tone in childhood.

Authors:  Rick Abbott
Journal:  Pediatr Clin North Am       Date:  2004-04       Impact factor: 3.278

10.  Comparison of botulinum toxin injection and neurotomy in patients with distal lower limb spasticity.

Authors:  M Rousseaux; N Buisset; W Daveluy; O Kozlowski; S Blond
Journal:  Eur J Neurol       Date:  2008-03-05       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.